Controlled Substances

4 Entries
 
 


Description

This presentation builds on the previous one in the series to show how to maintain the required controlled drug records in the most time-efficient way possible.

 This presentation builds on Part 1 and will include discussion of the new DEA form 222 and changes that are going into effect next year. Other subjects covered include Power of Attorney documentation  and controlled drug waste procedures.

Learning Points

By the end of this session participants will be able to (list skills):

1)      Set up a power of attorney for Controlled Drug management purposes under 21 CFR part 1305.05 (d) (1)

2)      Maintain electronic records of DEA forms 222 using the most recent procedures

3)      Legally dispose of surplus controlled substances using available methods of destruction

Presenter Bio

Jeffrey Vansplunder is Chairman of Airis Pharmaceuticals, who has extensive experience from his time as a police detective, undercover narcotics investigator, forensic scientific investigator, evidence officer, and white-collar crime investigator. AIRIS is dedicated to Comprehensive Opioid Drug Regulatory Compliance.Airis was founded by former law enforcement officers who were on the front lines working with businesses who administer and dispense controlled substances. They recognized client’s needs for someone to be an advocate between regulators and the opioid drug industry; ensuring compliance, exposing diversion & protecting clients’ interest.


#ControlledSubstancesCEonline
#FreeCEforMembers

Presenter 

Jeffrey Van Splunder

Description

The third webinar in our Controlled Drugs series builds on the foundation from the introductory webinar, also presented by Jeffrey VanSplunder of Airis Pharmaceutical Solutions.

It will go deeper into how to efficiently maintain DEA mandated records of controlled drugs. Have the peace of mind of knowing you are compliant by applying the practical steps delivered in this presentation.
 
 

Learning Points

  1. Understand the importance of establishing a system for maintaining controlled drug records

  2. Understand how to design a methodology that is efficient to use and complies with DEA laws

  3. Apply document templates to build your own controlled drug record system


Presenter Bio

Airis Pharmaceutical Solutions, Chairman and Founder. Licensed private investigator. Retired police detective, undercover narcotics investigator, forensic scientific investigator, evidence officer, white collar crime investigator.

Airis has been providing DEA compliant software, procedures, and consulting to veterinary practices since 2009

#FreeCEforMembers
#ControlledSubstancesCEonline

Clincial Security Practices and Documentation

Clinical Security Practices and Documentation
Recorded May 12, 2020  1 CE
This second webinar in our Controlled Drugs series builds on the foundation from the introductory webinar, also presented by Jeffrey VanSplunder of Airis Pharmaceutical Solutions.

The information discussed will include the additional documentation required to be maintained in a clinic's administrative book presented with applicable templates and examples as well as security practices and documentation.

AIRIS is dedicated to Comprehensive Opioid Drug Regulatory Compliance.

Airis was founded by former law enforcement officers who were on the front lines working with businesses who administer and dispense controlled substances. They recognized client’s needs for someone to be an advocate between regulators and the opioid drug industry; ensuring compliance, exposing diversion & protecting clients’ interest.



#ControlledSubstancesCEonline
#Featured



1 NYSED CE for NYSVMS members

This Introduction to Maintaining Controlled Drugs in a Clinical Environment will be presented by Jeffrey VanSplunder of Airis Pharmaceutical Solutions. The learning objectives are:
  • Identify the primary methods of diversion and strategies to prevent
  • Understand the factors that can trigger an inspection from the DEA
  • Prepare and maintain records in a manner that the DEA will determine is compliant with the law
  • How to screen employees who handle controlled substances
  • How to avoid liability by ensuring that controlled substance storage is secure

Jeffrey Vansplunder is Chairman of Airis Pharmaceuticals, who has extensive experience from his time as a police detective, undercover narcotics investigator, forensic scientific investigator, evidence officer, and white collar crime investigator.
AIRIS is dedicated to Comprehensive Opioid Drug Regulatory Compliance.

Airis was founded by former law enforcement officers who were on the front lines working with businesses who administer and dispense controlled substances. They recognized client’s needs for someone to be an advocate between regulators and the opioid drug industry; ensuring compliance, exposing diversion & protecting clients’ interest.

#ControlledSubstancesCEonline
#FreeCEforMembers